MIRA Pharmaceuticals Completes Phase 1 Dosing of Ketamir-2

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. ROST
5. BILL
6. WMT
7. ADI
8. MRK
9. MRNA
10. LOW

Go back to MIRA Pharmaceuticals Completes Phase 1 Dosing of Ketamir-2
Miracle Applications Corp (NASDAQ: MIRA) Delayed: 0.71 -0.06 (7.79%)
Previous Close $0.77    52 Week High $0.04 
Open $0.77    52 Week Low $0.00 
Day High $0.80    P/E N/A 
Day Low $0.71    EPS $0.00 
Volume 41,654